AKCEA THERAPEUTICS, INC. - 00972L107
Sector:
Healthcare
· Industry:
Pharmaceutical Preparations
Website:
No information yet
· Social:
No information yet
Company profile
Description is not available for this instrument yet.
Quarter snapshot
Latest / Compare
Q3 2020
· Q2 2020
Value (USD)
Total reported value ($000)
$216.3M
QoQ value delta ($000)
-$17.86M
(-7.63%)
Implied price effect (QoQ)
+32.39%
Shares
Total shares
11,922,968
QoQ shares delta
-5,165,941
(-30.23%)
Total shares held by funds (by quarter)
Top holders (Q3 2020)
Top 25 only
Full list
| Manager | Value ($000) | Shares | % of 13F |
|---|---|---|---|
| FMR LLC | 103,703 | 5,716,836 | 0.01% |
| VANGUARD GROUP INC | 24,904 | 1,372,903 | 0.0% |
| GABELLI FUNDS LLC | 10,877 | 599,625 | 0.08% |
| WELLS FARGO & COMPANY/MN | 8,126 | 447,981 | 0.0% |
| Bellevue Group AG | 6,172 | 340,264 | 0.09% |
| GEODE CAPITAL MANAGEMENT, LLC | 5,750 | 317,000 | 0.0% |
| STATE STREET CORP | 5,591 | 308,217 | 0.0% |
| RENAISSANCE TECHNOLOGIES LLC | 4,978 | 274,404 | 0.0% |
| NORTHERN TRUST CORP | 4,597 | 253,393 | 0.0% |
| Candriam Luxembourg S.C.A. | 4,433 | 244,395 | 0.04% |
| CITIGROUP INC | 3,993 | 220,124 | 0.0% |
| D. E. Shaw & Co., Inc. | 3,973 | 219,033 | 0.0% |
| GAMCO INVESTORS, INC. ET AL | 3,866 | 213,107 | 0.04% |
| MORGAN STANLEY | 3,548 | 195,555 | 0.0% |
| ALPS ADVISORS INC | 2,351 | 129,589 | 0.03% |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 2,011 | 110,837 | 0.0% |
| Caption Management, LLC | 1,523 | 84,000 | 0.04% |
| GOLDMAN SACHS GROUP INC | 1,334 | 73,522 | 0.0% |
| Qube Research & Technologies Ltd | 1,300 | 71,689 | 0.02% |
| Bank of New York Mellon Corp | 1,281 | 70,588 | 0.6% |
| Centiva Capital, LP | 907 | 50,000 | 0.06% |
| Walleye Capital LLC | 893 | 49,226 | 0.1% |
| Swiss National Bank | 818 | 45,100 | 0.0% |
| ALLIANCEBERNSTEIN L.P. | 780 | 43,000 | 0.0% |
| BARCLAYS PLC | 696 | 38,334 | 0.0% |